Comparison of 0.01% and 0.05% Atropine Eye Drops in Childhood Myopia Progression
Résumé
Abstract Background: Comparison of 0.01% and 0.05% atropine eye drops with every other day treatment for slowing down myopia progression in children. Methods: Children aged 5-16 years with myopia of -1.00-10.00 D and astigmatism less than -2.50 D and had myopic progression of at least 1.00D in the past year were included in the retrospective study. 0.01% and 0.05% atropine eye drops were applied every other day. At each visit, all patients underwent complete ophthalmic examination including cycloplegic refraction, axial length (AL), and photopic-mesopic pupil sizes. Spherical equivalent(SE), AL and photopic-mesopic pupil sizes were evaluated. Results: Totally 92 eyes of 46 patients were included in the study ( 22 0.01% atropin, 24 0.05% atropin). At the end of the 12-months follow- up period, tbe mean SE change was -0.41±0.28 D and -0,19±0.22 D in the 0.01% and %0.05 atropine groups, respectively (p<0.001). AL change was 0.19±0.16mm and 0.16±0.24mm in the 0.01% and 0.05% atropine groups, respectively (p=0.52). Side effects such as photophobia and blurred near vision were not observed in the 0.01% atropine group, but in the 0.05% atropine group, photophobia ( 3 patients) and blurred near vision ( 8 patients) were observed. Conclusions: 0.01% and 0.05% atropine eye drops significantly slow down the progression of myopia with every other day use. 0.01% atropine is better tolerated than 0.05% atropine.
Citer ce document
Accès au document
Texte intégral en lecture en ligne, réservé aux abonnés SPHAERO et aux membres de l'institution. Se connecter
Voir l'article sur le site de la revueAuteur(s)
Statistiques
Consultations : 1
Téléchargements : 0